Equities

Aurobindo Pharma Ltd

AUROPHARMA:NSI

Aurobindo Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,528.10
  • Today's Change-7.90 / -0.51%
  • Shares traded692.59k
  • 1 Year change+70.80%
  • Beta0.8892
Data delayed at least 15 minutes, as of Sep 19 2024 11:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue290,019248,554234,555
OPERATING EXPENSES
Cost of revenue total136,602123,259110,535
Selling, general and admin. expenses, total88,58981,89575,930
Depreciation/amortization14,91912,44611,265
Unusual expense(income)2,5422402,440
Other operating expenses, total5,3065,1833,170
Total operating expense248,714223,417203,992
Operating income41,30525,13630,563
Other, net1,8411,1732,070
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes43,80026,12533,727
Provision for income taxes12,1106,8497,256
Net income after taxes31,69019,27726,471
Minority interest40(1.5)10
Net income before extra. Items31,73019,27526,482
Total extraordinary items------
Net income31,73019,27526,482
Inc.avail. to common excl. extra. Items31,73019,27526,482
Inc.avail. to common incl. extra. Items31,73019,27526,482
EPS RECONCILIATION
Basic/primary weighted average shares586586586
Basic/primary eps excl. extra items543345
Basic/primary eps incl. extra items543345
Dilution adjustment------
Diluted weighted average shares586586586
Diluted eps excl. extra items543345
Diluted eps incl. extra items543345
COMMON STOCK DIVIDENDS
DPS - common stock primary issue4.503.009.00
Gross dividend - common stock2,6374,3952,637
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2,6811,290368
SUPPLEMENTAL INCOME
Depreciation, supplemental9,1818,3337,979
Total special items2,3071071,680
NORMALISED INCOME
Normalized income before taxes46,10726,23235,407
Effect of special items on income taxes63828361
Income tax excluding impact of special items12,7486,8777,618
Normalized income after tax33,35919,35627,790
Normalized income avail. to common33,39919,35427,800
Basic normalized EPS573347
Diluted normalized EPS573347
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.